RBBP8 and cancer: Hence, DNA damage-induced acetylation of CCAR2 is critically linked to the p53 apoptosis pathway and might have an effect on the choice of HR and NHEJ in a CtIP-dependent or -independent manner, thereby affecting the therapy response of cancers.